As the FDA reviews its insomnia drug daridorexant, Idorsia is getting its awareness campaign off the ground early, launching a new Alliance for Sleep to help boost education and research into a condition that often goes undiagnosed and can severely affect quality of life.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,